Abstract:OBJECTIVE:To explore gene expression of NANOG in T-cell acute lymphoblastic leukemia (T-ALL) cell lines and the effects of NANOG gene down-regulation on apoptosis of leukemia cells. METHODS:Real-time PCR (RT-PCR) and Western blot were used to detect the expression level of NANOG gene and protein in MOLT-4, CCRF-HSB2 and Jurkat cells. To test the efficiency of RNA interference, MOLT-4 cells were firstly infected by lentiviral vectors, which were successfully constructed with NANOG specific shRNA. NANOG expression levels were subsequently re-evaluated by RT-PCR and Western blot. The percentages of early apoptotic cells (Annexin V⁺/7-AAD⁻) and late apoptotic cells (Annexin V⁺/7-AAD⁺) were analyzed by flow cytometry. The expression of apoptosis-related genes was also detected. RESULTS:Both NANOG gene and protein expression was positive in MOLT-4 and CCRF-HSB2 cells. The lentiviral vectors pLB-shNANOG-1, pLB-shNANOG-2, and pLB-sh control were successfully constructed, as evidenced by the viral titers (1.83-3.12)× 10⁸ IU/ml. The experimental data on infection of MOLT-4 cells with such lentiviral vectors revealed that both shRNA interfering sequences (shNANOG-1 and shNANOG-2) could stably down-regulate NANOG gene and protein expressions. The percentages of early apoptotic cells in groups of shNANOG-1[(8.06 ± 1.61)%]and shNANOG-2[(5.67 ± 1.59)%]were significantly increased as compared to that of MOLT-4 group[(1.13 ± 0.40)%]or sh-control [(1.15±0.49)%](P<0.05). However, no statistical difference among them was observed for late apoptotic cells (P>0.05). The gene expression of TP53, PMAIP1, and CASP9 of either shNANOG-1 or shNANOG-2 group was augmented as compared to that of MOLT-4 group or sh-control (P<0.05). Reversely, a significant down-regulation of Bcl-2 gene expression was observed (P<0.05). CONCLUSION:NANOG can be expressed in various human T-ALL cell lines. Down-regulation of NANOG can trigger leukemia cellular apoptosis through mitochondria-dependent apoptosis pathway.

CpG-ODN down-regulates the expression of the functionally active Fas ligand in HeLa cells

CpG Oligonucleotides Suppress HepG2 Cells-Induced Jurkat Cell Apoptosis Via the Fas-FasL-mediated Pathway

Fas-mediated Pathway and Apoptosis in Normal Cervix, Cervical Intraepithelial Neoplasia and Cervical Squamous Cancer.

Effect of Fas Ligand Gene Transfection in Hela Cell on the Induction of Lymphocyte Apoptosis

[Up-Regulation of Fas is Related to Apoptosis of HeLa Cells Induced by Co-Immobilized TNF-alpha/IFN-gamma].

Effect of Up-expression of Fas Ligand on the Apoptosis of Gastric Carcinoma

T Cell Apoptosis Was Inhibited by Fas of Antisense Oligonucleotide

Toll-like Receptor Agonists Induce Apoptosis in Mouse B-cell Lymphoma Cells by Altering NF-κB Activation

Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications.

Effect of Selenium on the Expression of Fas/FasL in T Lymphocyte Anti Colonic Cancer Cells

Cervical carcinoma cell apoptosis and the expression of Fas and Fas ligand in human

[Effects of NANOG Gene Down-Regulation on the Apoptosis of T-cell Acute Lymphoblastic Leukemia Cells].

Cytokeratin 18 Regulates the Transcription and Alternative Splicing of Apoptotic‑related Genes and Pathways in HeLa Cells.

The Expression of Fas/FasL in Peripheral Blood Lymphocytes and the Level of IL-2 in Serum of Patients with Condyloma Acuminata

Analysis of Fas and Fas Ligand expression and function in lung cancer cell lines

Apoptosis of Active T Lymphocytes Induced by Human Laryngocarcinoma Cell Line

IFN-γ Regulates Fas/FasL Expression in Cholangio Carcinoma Cells

[Detection of Cell Apoptosis Induced with Anti-Fas Antibody in Bladder Carcinoma Cell Line by Single Cell Gel Electrophoresis].

The biological effect of Fas Ligand transfected HepG2 cell

Effects of CpG ODN on Dendritic Cells in Anti-Hepatocarcinoma Action

CpG Oligodeoxynucleotide Induces Apoptosis and Cell Cycle Arrest in A20 Lymphoma Cells Via TLR9-mediated Pathways